Machine learning identifies clinical sepsis phenotypes that translate to the plasma proteome.
Source check: Source checked. Not independent scientific confirmation.
Finding: In 384 prospective multicenter sepsis patients, clinical-data clustering identified three severity phenotypes; plasma proteomics characterized them and supervised ML classified them. This is an observational phenotype result, not evidence of treatment benefit. The reviewed source supports this bounded result; external generalization, causal effects, and sustained operational impact remain unestablished where the source reports retrospective or internal evaluation.
Technology: unsupervised clustering/PCA of routine ICU clinical variables defines phenotypes; supervised Random Forest classifies phenotypes, and mass-spectrometry proteomics characterizes them.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- unsupervised clustering/PCA of routine ICU clinical variables defines phenotypes; supervised Random Forest classifies phenotypes, and mass-spectrometry proteomics characterizes them.
- Test and result
- 384 prospective sepsis patients formed three severity phenotypes with different SOFA/mortality trajectories and corresponding plasma-proteome patterns.
- Limitation / still unknown
- Methods: 70/30 training/test split and 100-iteration Monte Carlo cross-validation for classifier evaluation. The observed multicenter clinical outcomes and proteomics support phenotype characterization; this does not show a treatment effect.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1007/s15010-025-02628-3 · https://api.biorxiv.org/details/medrxiv/2025-04-11/2025-04-12/0 · https://www.medrxiv.org/content/10.1101/2025.04.11.25325574v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.